MicroRNA-7: A promising new target in cancer therapy

83Citations
Citations of this article
96Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The incidence of tumors with life-threatening effects has increased gradually over time; however, the mechanisms involved in tumor development have not been fully elucidated. Recent studies have shown that microRNA-7 (miR-7), which is endogenous non-coding RNA molecules of approximately 23 nucleotides, plays an important role in the occurrence and development of tumors as a key tumor suppressor. Mechanistic evidence showed that miR-7 is closely related to the growth, metastasis, and prognosis of various malignant tumors through regulating different target molecules, which suggest that miR-7 may be a new target for the clinical diagnosis and treatment of various tumors. In this review, we summarize current knowledge of the relationship between miR-7 and tumor development, diagnosis, and treatment.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhao, J., Tao, Y., Zhou, Y., Qin, N., Chen, C., Tian, D., & Xu, L. (2015, October 29). MicroRNA-7: A promising new target in cancer therapy. Cancer Cell International. BioMed Central Ltd. https://doi.org/10.1186/s12935-015-0259-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free